Artia Global Partners’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,992,367
Closed -$4.16M – 56
2026
Q2
$4.16M Hold
1,992,367
– – 0.77% 29
2026
Q1
$3.49M Hold
1,992,367
– – 0.7% 28
2025
Q4
$4.68M Buy
+1,992,367
New +$3.83M 0.66% 25

Other funds holding PALI

Artia Global Partners's PALI Position: Q3 2026 in Review

Artia Global Partners sold out of Palisade Bio (PALI) in Q3 2026, closing a stake of 1,992,367 shares — an estimated $4.16M sold.

Artia Global Partners first reported a position in PALI in Q4 2025 and held it in 3 quarters. The position peaked at $4.68M in Q4 2025. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Artia Global Partners reported no remaining Palisade Bio position as of Q3 2026 after selling out during the quarter.
  • Artia Global Partners sold 1,992,367 Palisade Bio shares in Q3 2026, an estimated $4.16M.
  • Artia Global Partners first reported a position in Palisade Bio in Q4 2025 and held it in 3 quarters.
  • Artia Global Partners's Palisade Bio position peaked at $4.68M in Q4 2025.
  • 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Artia Global Partners's 13F filing for Q3 2026, filed 16 Nov 2026.